Endo International PLC Company Profile (NASDAQ:ENDP)

About Endo International PLC (NASDAQ:ENDP)

Endo International PLC logoEndo International PLC, formerly Endo Health Solutions Inc. is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel. The Company operates in three segments: Endo Pharmaceuticals, Qualitest and AMS. In June 2014, the Company's subsidiary, Endo Pharmaceuticals sold its pharmaceutical drug discovery platform to AsanaBioSciences, LLC. In June 2014, Asana BioSciences, LLC, an independent member of Amneal Alliance of Companies, acquired early-stage branded pharmaceutical discovery platform of Endo Pharmaceuticals, a subsidiary of Endo International plc. In June 2014, Trendlines Group acquired intellectual property developed within the framework of an R&D agreement with the Company. In July 2014, it acquired Grupo Farmaceutico Somar.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Other
  • Sub-Industry: Pharmaceuticals
  • Symbol: NASDAQ:ENDP
  • CUSIP: 29264F20
  • Web: www.endo.com
Capitalization:
  • Market Cap: $1.87342 billion
  • Outstanding Shares: 223,292,000
Average Prices:
  • 50 Day Moving Avg: $8.73
  • 200 Day Moving Avg: $10.80
  • 52 Week Range: $7.41 - $23.98
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 2.79
  • P/E Growth: -0.13
Sales & Book Value:
  • Annual Revenue: $4.04 billion
  • Price / Sales: 0.48
  • Book Value: $3.62 per share
  • Price / Book: 2.38
Profitability:
  • EBIDTA: $313.33 million
  • Net Margins: -126.93%
  • Return on Equity: 37.58%
  • Return on Assets: 7.68%
Debt:
  • Debt-to-Equity Ratio: 10.20%
  • Current Ratio: 1.02%
  • Quick Ratio: 0.80%
Misc:
  • Average Volume: 5.87 million shs.
  • Beta: 0.64
  • Short Ratio: 5.39
 

Frequently Asked Questions for Endo International PLC (NASDAQ:ENDP)

What is Endo International PLC's stock symbol?

Endo International PLC trades on the NASDAQ under the ticker symbol "ENDP."

How were Endo International PLC's earnings last quarter?

Endo International PLC (NASDAQ:ENDP) released its earnings results on Tuesday, August, 8th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.74 by $0.19. The business had revenue of $875.73 million for the quarter, compared to analyst estimates of $832.66 million. Endo International PLC had a positive return on equity of 37.58% and a negative net margin of 126.93%. Endo International PLC's revenue was down 4.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.86 earnings per share. View Endo International PLC's Earnings History.

When will Endo International PLC make its next earnings announcement?

Endo International PLC is scheduled to release their next quarterly earnings announcement on Tuesday, November, 14th 2017. View Earnings Estimates for Endo International PLC.

What guidance has Endo International PLC issued on next quarter's earnings?

Endo International PLC issued an update on its FY17 earnings guidance on Tuesday, August, 8th. The company provided earnings per share guidance of $3.35-3.65 for the period, compared to the Thomson Reuters consensus estimate of $3.53. The company issued revenue guidance of $3.38-3.53 billion, compared to the consensus revenue estimate of $3.49 billion.

Where is Endo International PLC's stock going? Where will Endo International PLC's stock price be in 2017?

20 analysts have issued twelve-month target prices for Endo International PLC's shares. Their predictions range from $8.00 to $27.00. On average, they expect Endo International PLC's share price to reach $14.50 in the next year. View Analyst Ratings for Endo International PLC.

What are analysts saying about Endo International PLC stock?

Here are some recent quotes from research analysts about Endo International PLC stock:

  • 1. According to Zacks Investment Research, "2017 will continue to be challenging for Endo as the generics base business and the legacy branded pain franchise are expected to decline further. Shares of Endo have significantly underperformed the Medical-Drugs industry in the past one year. The company’s Generic segment is also under pressure given the challenging competitive landscape and pricing pressures. With the  company pulling off Opana ER from the market over growing concern of opioid abuse epidemic, the top-line will be further impacted. Also, the Branded segment continues to be under pressure due to additional competitive entrants as well as a continuous rise in the number of public policy and regulatory actions. Nevertheless, Endo’s growth-by-acquisition strategy is impressive. Endo’s top line should continue to benefit from robust performance of Xiaflex and sterile injectables." (7/28/2017)
  • 2. JMP Securities analysts commented, "The FDA panel voted 8 yes, 18 no, and 1 abstain on whether Opana ER's benefits outweigh the risk. The FDA was concerned that the new Opana ER formulation just shifts the abuse route from nasal to injections. We do not view Opana ER as a growth driver and it is only 4% of our 2017 revenue estimate while declining 13% y/y. Our $20 price target includes an equal blend of PEG ratio and EV/EBITDA analysis of 1.3x and 8.5x, respectively, on our 2017 estimates." (3/15/2017)
  • 3. Royal Bank Of Canada analysts commented, "Yesterday's AdComs' vote of 18 to 8 (one abstain) on OPANA ER's benefits no longer outweighing its risks will push a decision on the product's fate back to FDA. Whether it is removed or sees added restrictions we think it is likely we will see some downward P&L pressure but it is also worth noting that the stock was -25% in Mar ahead of the anticipated panel." (3/15/2017)
  • 4. Mizuho analysts commented, " We still like ENDP and its significant optionality, and we see upside to the stock for the following reasons: (1) Endo can likely sell Xiaflex for a healthy multiple with minimal EBITDA downside after cutting $30M in R&D expense for the planned cellulite trial and expenses tied to ~100 reps. (2) Endo may beat expectations following its conservative guide and/or longer than expected persistence of the Somar business, which is now also for sale. (3) Its high gross margin (55%) generic business with an attractive 117 ANDA pipeline, with 35 "first to files", is likely to attract consolidators in our view. (4) Its U.S.-based manufacturing plants contributed 95% of its production based on revenue, which may appeal to a potential buyer in the current political environment. We attribute remaining risk to a potential increase to the mesh liability accrual, but the company always has the option to litigate and delay. ENDP could therefore work in 2017 following an asset sale or takeover speculation. We reiterate our Buy rating and raise PT to $17 from $15 as we lower our WACC to 10% from 11% after mgmt. re-set expectations and the outlook." (3/3/2017)
  • 5. Guggenheim analysts commented, "ENDP reported a 4Q16 beat and guided down for '17, which was expected given pricing pressure in generics. Lack of earnings visibility in '18 remains a concern. That said, we think patience will be rewarded and execution against its stated objectives will drive multiple expansion for ENDP's stock toward our $35 PT. Also, ENDP continues to be open to strategic alternatives if it cannot enhance shareholder value on its own. We think ENDP could simplify its business by selling its brand assets to pay down debt. In our view, ENDP is also an interesting generics asset (#4 player) in a consolidating industry." (2/28/2017)

Are investors shorting Endo International PLC?

Endo International PLC saw a increase in short interest in the month of August. As of August 31st, there was short interest totalling 24,909,389 shares, an increase of 29.4% from the August 15th total of 19,253,632 shares. Based on an average trading volume of 6,579,469 shares, the short-interest ratio is presently 3.8 days. Approximately 12.5% of the shares of the stock are sold short.

Who are some of Endo International PLC's key competitors?

Who owns Endo International PLC stock?

Endo International PLC's stock is owned by a number of of retail and institutional investors. Top institutional investors include Capital Research Global Investors (4.71%), State Street Corp (3.24%), Bank of New York Mellon Corp (1.01%), First Quadrant L P CA (0.92%), Acadian Asset Management LLC (0.50%) and Tekla Capital Management LLC (0.41%). Company insiders that own Endo International PLC stock include Arthur J Higgins, Blaise Coleman, Matthew Joseph Maletta, Michael Hyatt, Nancy J Hutson, Paul Campanelli, Roger H Kimmel, Shane Cooke, Silva Rajiv De, Suketu Upadhyay, Susan Hall, Terrance J Coughlin and William Spengler. View Institutional Ownership Trends for Endo International PLC.

Who sold Endo International PLC stock? Who is selling Endo International PLC stock?

Endo International PLC's stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Acadian Asset Management LLC, Balyasny Asset Management LLC, First Quadrant L P CA, New York State Common Retirement Fund, Oregon Public Employees Retirement Fund, Thrivent Financial For Lutherans and State Street Corp. Company insiders that have sold Endo International PLC stock in the last year include Nancy J Hutson and Roger H Kimmel. View Insider Buying and Selling for Endo International PLC.

Who bought Endo International PLC stock? Who is buying Endo International PLC stock?

Endo International PLC's stock was bought by a variety of institutional investors in the last quarter, including Diamond Hill Capital Management Inc., Canada Pension Plan Investment Board, Sivik Global Healthcare LLC, River & Mercantile Asset Management LLP, Quantitative Investment Management LLC, Columbia Partners L L C Investment Management, Nomura Holdings Inc. and Parametric Portfolio Associates LLC. Company insiders that have bought Endo International PLC stock in the last two years include Arthur J Higgins, Blaise Coleman, Matthew Joseph Maletta, Paul Campanelli, Roger H Kimmel, Shane Cooke, Silva Rajiv De, Suketu Upadhyay, Susan Hall, Terrance J Coughlin and William Spengler. View Insider Buying and Selling for Endo International PLC.

How do I buy Endo International PLC stock?

Shares of Endo International PLC can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Endo International PLC's stock price today?

One share of Endo International PLC stock can currently be purchased for approximately $8.62.


MarketBeat Community Rating for Endo International PLC (NASDAQ ENDP)
Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  600 (Vote Outperform)
Underperform Votes:  560 (Vote Underperform)
Total Votes:  1,160
MarketBeat's community ratings are surveys of what our community members think about Endo International PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Endo International PLC (NASDAQ:ENDP) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 15 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $14.50 (68.21% upside)

Analysts' Ratings History for Endo International PLC (NASDAQ:ENDP)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/17/2017Piper Jaffray CompaniesReiterated RatingHold$9.00MediumView Rating Details
9/12/2017MizuhoReiterated RatingBuy$19.00 -> $14.00LowView Rating Details
8/14/2017Canaccord GenuitySet Price TargetHold$10.00HighView Rating Details
8/11/2017BMO Capital MarketsReiterated RatingMarket Perform$15.00 -> $11.00LowView Rating Details
8/10/2017Morgan StanleyLower Price TargetEqual Weight$12.00 -> $8.00LowView Rating Details
8/10/2017Cowen and CompanyReiterated RatingHold$16.00HighView Rating Details
8/10/2017Citigroup Inc.Reiterated RatingNeutral$14.00 -> $11.00HighView Rating Details
8/10/2017Royal Bank Of CanadaSet Price TargetHold$15.00 -> $9.00HighView Rating Details
8/9/2017Deutsche Bank AGSet Price TargetBuy$15.00 -> $13.00LowView Rating Details
8/8/2017Oppenheimer Holdings, Inc.Reiterated RatingHoldHighView Rating Details
8/8/2017Cantor FitzgeraldSet Price TargetHold$12.00 -> $9.00MediumView Rating Details
6/17/2017GuggenheimInitiated CoverageHold$12.00MediumView Rating Details
6/14/2017William BlairReiterated RatingMarket PerformLowView Rating Details
6/9/2017Stifel NicolausDowngradeBuy -> Hold$22.00 -> $15.00HighView Rating Details
3/20/2017Leerink SwannReiterated RatingMarket PerformLowView Rating Details
3/15/2017JMP SecuritiesReiterated RatingOutperform$20.00HighView Rating Details
2/6/2017Barclays PLCLower Price TargetEqual Weight$22.00 -> $15.00N/AView Rating Details
1/31/2017Susquehanna Bancshares IncUpgradeNeutral -> PositiveN/AView Rating Details
1/20/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$20.00N/AView Rating Details
9/29/2016Northland SecuritiesUpgradeMarket Perform -> Outperform$27.00N/AView Rating Details
6/6/2016Goldman Sachs Group, Inc. (The)Initiated CoverageNeutral$20.00N/AView Rating Details
4/2/2016NomuraReiterated RatingBuyN/AView Rating Details
11/13/2015Standpoint ResearchUpgradeHold -> Buy$75.00N/AView Rating Details
(Data available from 9/21/2015 forward)

Earnings

Earnings History for Endo International PLC (NASDAQ:ENDP)
Earnings by Quarter for Endo International PLC (NASDAQ:ENDP)
Earnings History by Quarter for Endo International PLC (NASDAQ ENDP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017$0.66N/AView Earnings Details
8/8/20176/30/2017$0.74$0.93$832.66 million$875.73 millionViewListenView Earnings Details
5/9/2017Q1 17$1.10$1.23$1.02 billion$1.04 billionViewListenView Earnings Details
2/28/2017Q416$1.63$1.77$1.17 billion$1.24 billionViewListenView Earnings Details
11/8/2016Q316$0.81$1.01$862.47 million$894.30 millionViewListenView Earnings Details
8/8/2016Q216$0.74$0.86$873.50 million$921.00 millionViewListenView Earnings Details
5/5/2016Q116$1.04$1.08$960.96 million$963.54 millionViewListenView Earnings Details
2/29/2016Q415$1.27$1.36$1.07 billion$1.07 billionViewListenView Earnings Details
11/5/2015Q315$1.00$1.02$736.16 million$746.00 millionViewListenView Earnings Details
8/10/2015Q215$1.02$1.08$727.45 million$735.00 millionViewListenView Earnings Details
5/11/2015Q115$1.07$1.17$714.42 million$714.00 millionViewListenView Earnings Details
3/2/2015Q414$1.13$1.16$780.44 million$800.00 millionViewListenView Earnings Details
11/5/2014Q314$0.99$1.15$721.11 million$764.00 millionViewListenView Earnings Details
7/31/2014Q214$0.90$1.06$644.60 million$719.00 millionViewListenView Earnings Details
5/1/2014Q114$0.84$0.92$608.86 million$595.00 millionViewListenView Earnings Details
2/28/2014Q413$0.93$0.96$620.90 million$584.95 millionViewListenView Earnings Details
11/7/2013Q313$1.11$1.34$695.63 million$715.00 millionViewListenView Earnings Details
8/6/2013Q2 2013$1.15$1.42$721.01 million$766.51 millionViewListenView Earnings Details
5/7/2013Q1 2013$1.08$1.09$737.79 million$709.00 millionViewListenView Earnings Details
2/28/2013Q4 2012$1.54$1.62$807.98 million$801.06 millionViewListenView Earnings Details
11/5/2012Q312$1.26$1.28$788.53 million$750.50 millionViewN/AView Earnings Details
8/7/2012$1.19$1.27ViewN/AView Earnings Details
5/1/2012$0.86$0.87ViewN/AView Earnings Details
2/24/2012$1.32$1.40ViewN/AView Earnings Details
10/27/2011$1.28$1.25ViewN/AView Earnings Details
8/9/2011$1.06$1.05ViewN/AView Earnings Details
4/28/2011$1.00$1.00ViewN/AView Earnings Details
2/28/2011$0.97$1.06ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Endo International PLC (NASDAQ:ENDP)
2017 EPS Consensus Estimate: $3.35
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$1.08$1.26$1.15
Q2 20173$0.75$0.80$0.77
Q3 20173$0.65$0.74$0.69
Q4 20173$0.64$0.84$0.73
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Endo International PLC (NASDAQ:ENDP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Endo International PLC (NASDAQ:ENDP)
Insider Ownership Percentage: 0.50%
Institutional Ownership Percentage: 90.71%
Insider Trades by Quarter for Endo International PLC (NASDAQ:ENDP)
Institutional Ownership by Quarter for Endo International PLC (NASDAQ:ENDP)
Insider Trades by Quarter for Endo International PLC (NASDAQ:ENDP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2017Blaise ColemanCFOBuy6,500$7.89$51,285.00View SEC Filing  
8/15/2017Matthew Joseph MalettaEVPBuy3,000$8.02$24,060.00View SEC Filing  
8/14/2017Paul CampanelliCEOBuy6,500$7.71$50,115.00View SEC Filing  
8/10/2017Terrance J CoughlinCOOBuy20,000$7.70$154,000.00View SEC Filing  
3/16/2017Paul CampanelliCEOBuy2,300$10.72$24,656.00View SEC Filing  
3/9/2017Nancy J. HutsonDirectorSell5,325$10.82$57,616.50View SEC Filing  
11/15/2016Roger H. KimmelDirectorSell14,000$17.38$243,320.00View SEC Filing  
5/11/2016Arthur J HigginsDirectorBuy5,000$13.80$69,000.00View SEC Filing  
5/10/2016Arthur J HigginsDirectorBuy11,000$15.42$169,620.00View SEC Filing  
5/10/2016Paul CampanelliInsiderBuy13,000$15.53$201,890.00View SEC Filing  
3/17/2016William SpenglerDirectorBuy1,000$29.20$29,200.00View SEC Filing  
3/16/2016William SpenglerDirectorBuy1,000$35.24$35,240.00View SEC Filing  
3/14/2016Roger H KimmelDirectorBuy1,125$41.94$47,182.50View SEC Filing  
3/7/2016Matthew Joseph MalettaVPBuy500$44.48$22,240.00View SEC Filing  
3/7/2016Silva Rajiv DeCEOBuy2,250$44.50$100,125.00View SEC Filing  
3/1/2016Nancy J. HutsonDirectorSell3,413$42.19$143,994.47View SEC Filing  
11/12/2015Shane CookeDirectorBuy4,000$57.13$228,520.00View SEC Filing  
11/11/2015Michael HyattDirectorSell8,000$55.48$443,840.00View SEC Filing  
11/11/2015Paul CampanelliinsiderBuy2,100$55.69$116,949.00View SEC Filing  
11/11/2015Silva Rajiv DeCEOBuy9,006$55.52$500,013.12View SEC Filing  
11/11/2015Suketu UpadhyayCFOBuy4,450$56.37$250,846.50View SEC Filing  
11/11/2015Susan HallEVPBuy1,000$55.35$55,350.00View SEC Filing  
6/16/2015Arthur J HigginsDirectorBuy2,500$81.10$202,750.00View SEC Filing  
4/8/2015Caroline B ManogueVPSell105,562$91.90$9,701,147.80View SEC Filing  
11/14/2014Suketu UpadhyayCFOBuy3,700$66.94$247,678.00View SEC Filing  
8/5/2014Arthur J HigginsDirectorBuy3,500$65.65$229,775.00View SEC Filing  
6/9/2014John DeluccaDirectorSell6,764$68.83$465,566.12View SEC Filing  
5/29/2014Caroline B ManogueVPSell175,033$72.02$12,605,876.66View SEC Filing  
5/1/2014John DeluccaDirectorSell8,094$66.31$536,713.14View SEC Filing  
4/1/2014John DeluccaDirectorSell10,384$68.46$710,888.64View SEC Filing  
3/10/2014Arthur HigginsDirectorBuy5,000$73.00$365,000.00View SEC Filing  
3/10/2014Ivan GergelEVPSell75,637$72.47$5,481,413.39View SEC Filing  
8/26/2013Caroline ManogueVPSell145,592$39.40$5,736,324.80View SEC Filing  
8/8/2013Roger KimmelDirectorBuy5,478$36.50$199,947.00View SEC Filing  
4/9/2013Caroline B ManogueVPSell35,000$35.00$1,225,000.00View SEC Filing  
11/12/2012David HolveckCEOBuy7,425$26.84$199,287.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Endo International PLC (NASDAQ:ENDP)
Latest Headlines for Endo International PLC (NASDAQ:ENDP)
Source:
DateHeadline
businesswire.com logoENDP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of ...
www.businesswire.com - September 21 at 12:13 AM
businesswire.com logoENDP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action ... - Business Wire (press release)
www.businesswire.com - September 20 at 7:10 PM
finance.yahoo.com logoENDP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of October 17, 2017
finance.yahoo.com - September 20 at 7:10 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 20 at 7:10 PM
nasdaq.com logoAre Options Traders Betting on a Big Move in Endo International (ENDP) Stock? - Nasdaq
www.nasdaq.com - September 19 at 11:17 PM
seekingalpha.com logoEndo Is Not Out Of Woods Yet - Seeking Alpha
seekingalpha.com - September 19 at 11:17 PM
finance.yahoo.com logoAre Options Traders Betting on a Big Move in Endo International (ENDP) Stock?
finance.yahoo.com - September 19 at 6:17 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces a Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 19 at 6:17 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 18 at 6:07 PM
finance.yahoo.com logoValeant Pharmaceuticals: Is A New Drug Approval On The Horizon?
finance.yahoo.com - September 18 at 6:07 PM
finance.yahoo.com logoEQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Endo International plc and Set a Lead Plaintiff Deadline of October 17, 2017
finance.yahoo.com - September 18 at 6:07 PM
americanbankingnews.com logoPiper Jaffray Companies Reaffirms "Hold" Rating for Endo International PLC (ENDP)
www.americanbankingnews.com - September 17 at 7:06 AM
finance.yahoo.com logoThe Klein Law Firm Notifies Investors of Commencement of a Class Action Filed on Behalf of Endo International plc Shareholders and a Lead Plaintiff Deadline of October 17, 2017
finance.yahoo.com - September 16 at 5:46 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Endo International plc
finance.yahoo.com - September 16 at 5:46 PM
businesswire.com logoENDO LOSS NOTICE: Rosen Law Firm Reminds Endo International plc Investors of Important Deadline in Class Action ... - Business Wire (press release)
www.businesswire.com - September 15 at 6:47 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 15 at 6:47 PM
finance.yahoo.com logoENDO LOSS NOTICE: Rosen Law Firm Reminds Endo International plc Investors of Important Deadline in Class Action – ENDP
finance.yahoo.com - September 15 at 6:47 PM
americanbankingnews.com logoZacks: Analysts Anticipate Endo International PLC (ENDP) Will Post Quarterly Sales of $780.75 Million
www.americanbankingnews.com - September 15 at 1:46 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo International plc (ENDP) & Lead Plaintiff Deadline: October 17, 2017
finance.yahoo.com - September 14 at 6:54 PM
finance.yahoo.com logoIMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 14 at 6:54 PM
americanbankingnews.com logoShort Interest in Endo International PLC (ENDP) Increases By 29.4%
www.americanbankingnews.com - September 14 at 1:54 AM
americanbankingnews.com logoEndo International PLC (ENDP) Expected to Announce Earnings of $0.67 Per Share
www.americanbankingnews.com - September 14 at 12:24 AM
businesswire.com logoENDP EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of ...
www.businesswire.com - September 13 at 7:37 PM
finance.yahoo.com logoENDP EQUITY ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of October 17, 2017
finance.yahoo.com - September 13 at 7:37 PM
finance.yahoo.com logoIMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Endo International plc and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - September 13 at 7:37 PM
finance.yahoo.com logoETFs with exposure to Endo International Plc : September 13, 2017
finance.yahoo.com - September 13 at 7:37 PM
globenewswire.com logoENDP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Endo ... - GlobeNewswire (press release)
globenewswire.com - September 13 at 12:09 AM
streetinsider.com logoEndo International plc (ENDP) PT Lowered to $14 at Mizuho Securities - StreetInsider.com
www.streetinsider.com - September 13 at 12:09 AM
finance.yahoo.com logoENDP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Endo International plc and a Lead Plaintiff Deadline of October 17, 2017
finance.yahoo.com - September 12 at 7:07 PM
finance.yahoo.com logoINVESTOR ALERT: Goldberg Law PC Announces the Filing of a Securities Class Action Lawsuit against Endo International plc
finance.yahoo.com - September 12 at 7:07 PM
americanbankingnews.com logoEndo International PLC (ENDP) Given Buy Rating at Mizuho
www.americanbankingnews.com - September 12 at 2:34 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo International plc (ENDP) & Lead Plaintiff Deadline: October 17, 2017
finance.yahoo.com - September 11 at 11:55 PM
prnewswire.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Endo ... - PR Newswire (press release)
www.prnewswire.com - September 11 at 6:53 PM
nasdaq.com logoJanuary 2020 Options Now Available For Endo International (ENDP) - Nasdaq
www.nasdaq.com - September 11 at 6:53 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Endo International plc and Set a Lead Plaintiff Deadline of October 17, 2017 -- ENDP
finance.yahoo.com - September 11 at 6:52 PM
finance.yahoo.com logoEndo International Plc :ENDP-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
finance.yahoo.com - September 11 at 6:52 PM
businesswire.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endo International plc ... - Business Wire (press release)
www.businesswire.com - September 10 at 10:37 PM
finance.yahoo.com logoEQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Endo International plc – ENDP
finance.yahoo.com - September 8 at 6:43 PM
finance.yahoo.com logoThe Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Endo International plc
finance.yahoo.com - September 5 at 7:53 PM
finance.yahoo.com logoWhy Mallinckrodt Got Crushed
finance.yahoo.com - September 5 at 7:53 PM
americanbankingnews.com logoEndo International PLC (ENDP) Downgraded by ValuEngine to Hold
www.americanbankingnews.com - September 3 at 2:04 PM
americanbankingnews.com logoEndo International PLC (ENDP) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - September 2 at 4:30 PM
finance.yahoo.com logoThe Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Endo International plc
finance.yahoo.com - August 31 at 6:08 PM
finance.yahoo.com logoIMPORTANT ENDO INTERNATIONAL PLC INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Pennsylvania on behalf of investors who purchased Endo International plc
finance.yahoo.com - August 30 at 7:31 PM
finance.yahoo.com logoEndo Begins Shipment of Generic Sabril® (vigabatrin) for Oral Solution
finance.yahoo.com - August 28 at 6:03 PM
finance.yahoo.com logoWill Endo (ENDP) Continue to Disappoint Investors in 2017?
finance.yahoo.com - August 25 at 7:54 PM
finance.yahoo.com logoEndo to Participate at Morgan Stanley Global Healthcare Conference
finance.yahoo.com - August 22 at 11:54 PM
americanbankingnews.com logoEndo International PLC (ENDP) Upgraded by BidaskClub to "Sell"
www.americanbankingnews.com - August 19 at 11:50 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in Endo International plc and Set a Lead Plaintiff Deadline of October 17, 2017
finance.yahoo.com - August 18 at 6:14 PM
finance.yahoo.com logoEndo International (ENDP) Jumps: Stock Rises 6.9%
finance.yahoo.com - August 17 at 7:33 PM

Social

Chart

Endo International PLC (ENDP) Chart for Thursday, September, 21, 2017

This page was last updated on 9/21/2017 by MarketBeat.com Staff